In addition, it addresses the FDA’s communications Together with the applicant, the retention of information that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report back to a different applicant and electronic submission from